Long-term follow-up of HER2-overexpressing stage II or III breast cancer treated by anthracycline-free neoadjuvant chemotherapy
2011 ◽
Vol 22
(2)
◽
pp. 321-328
◽
S. Guiu
◽
M. Liegard
◽
L. Favier
◽
I. van Praagh
◽
R. Largillier
◽
...
2011 ◽
Vol 29
(15_suppl)
◽
pp. e11048-e11048
S. Nimmagadda
◽
L. Nabell
◽
J. T. Carpenter
◽
C. I. Falkson
◽
H. Krontiras
◽
...
2012 ◽
Vol 20
(4)
◽
pp. 357-362
◽
Pramod K. Julka
◽
Raju T. Chacko
◽
Shona Nag
◽
Rajinder Parshad
◽
Aravindan Nair
◽
...
Hiroko Nogi
◽
Ken Uchida
◽
Makiko Kamio
◽
Kumiko Kato
◽
Yasuo Toriumi
◽
...
S. Guiu
◽
L. Arnould
◽
B. Coudert
◽
M. Liégard
◽
F. Mayer
◽
...
2017 ◽
Vol 17
(8)
◽
pp. 644-649
◽
Hiroko Nogi
◽
Ken Uchida
◽
Rei Mimoto
◽
Makiko Kamio
◽
Hisashi Shioya
◽
...
1992 ◽
Vol 66
(6)
◽
pp. 1171-1176
◽
C Blomqvist
◽
K Tiusanen
◽
I Elomaa
◽
P Rissanen
◽
T Hietanen
◽
...
2019 ◽
Vol 19
(4)
◽
pp. e540-e546
Hugo Gornes
◽
Bastien Cabarrou
◽
Eva Jouve
◽
Camille Franchet
◽
Hélène Charitansky
◽
...
Gilberto Schwartsmann
◽
Fabio Leal
2004 ◽
Vol 130
(6)
◽
pp. 327-333
◽
Hans Geinitz
◽
Frank B. Zimmermann
◽
Reinhard Thamm
◽
Monika Keller
◽
Raymonde Busch
◽
...
Lucie Veron
◽
Delphine Wehrer
◽
Gisèle Annerose-Zephir
◽
Dan Chaltiel
◽
Suzette Delaloge
◽
...